GSK’s Arexvy has received expanded approval in Canada for preventing RSV-related lower respiratory tract disease in adults ...

Phenylephrine:CVS pulls cold medicines with the ingredient Companies such as Procter & Gamble and GSK were among several accused in lawsuits of deceiving consumers about cold medicines containing the ...

Vesalius Will Apply its Proprietary Platform to Identify Novel Intervention Points that GSK may Advance for the Treatment of Patients with Parkinson’s Disease GSK has Licensed a Preclinical Small ...

UnitedHealth may not be able to maintain its double-digit revenue long term. GSK, formerly known as GlaxoSmithKline, continues to distinguish itself through its vast array of medicines ...

Reports Q3 revenue $89.5M, two estimates $76.9M. “For the third quarter of 2024, we continue to deliver strong revenue growth, with solid ...

Discussion meet on the impact of Nobel Prize winners in Economics on Indian development, focusing on institutions and democracy.

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

Taxes are different depending on location, so when an address might be incorrectly provided, for example with the State Sales ...

The "CC Chemokine Receptor Type 5 Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The CC ...

Pfizer was founded in 1849 by two recent German immigrants to the USA, Charles Pfizer and Charles ... but buyers including Proctor & Gamble and GSK pulled out of negotiations.

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...